SCHEMBL7708436

SCHEMBL7708436

CSc1ncc(Oc2ccc(Cl)cc2)c(=O)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
POLB P06746 2/20 0.50
NPC1 O15118 1/20 0.50
MAPK1 P28482 1/20 0.50
RAB9A P51151 1/20 0.50
GFER P55789 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
KDM6B O15054 1/20 0.43
KDM4A O75164 1/20 0.43
KDM4D Q6B0I6 1/20 0.43
HIF1AN Q9NWT6 1/20 0.43
KDM2A Q9Y2K7 1/20 0.43
DAO P14920 3/20 0.40
KDM4C Q9H3R0 2/20 0.39
LTA4H P09960 1/20 0.38
CCNC P24863 2/20 0.37
CDK8 P49336 2/20 0.37
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
SLC2A1 P11166 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10618505 0.82 LMNA (0.51) LMNAPOLBL3MBTL1KDM6BKDM4A
SCHEMBL11466777 0.79 PLA2G7 (0.52) LMNAPOLBNPC1MAPK1RAB9A
SCHEMBL10982229 0.78 LMNA (0.53) LMNAGFERKDM6BKDM4AKDM4D
SCHEMBL5202998 0.78 LTA4H (0.57) DAOKDM4CLTA4HCCNCCDK8
SCHEMBL5207646 0.78 KDM4C (0.41) LMNAPOLBL3MBTL1DAOKDM4C
SCHEMBL7716750 0.77 KDM4C (0.40) RAB9ADAOKDM4CLTA4HCCNC
SCHEMBL11900387 0.75 LMNA (0.59) LMNAPOLBNPC1MAPK1RAB9A
SCHEMBL11069011 0.72 LMNA (0.50) LMNAPOLBNPC1MAPK1RAB9A
SCHEMBL10652057 0.71 PLA2G7 (0.58) LMNAPOLBNPC1MAPK1RAB9A
SCHEMBL7712513 0.71 HRH4 (0.49) POLBCCNCCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed